| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.0097 | 0.9 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.9 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |